Octavia Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,847
Closed -$205K 264
2025
Q2
$205K Sell
1,847
-34
-2% -$3.62K 0.02% 221
2025
Q1
$211K Buy
+1,881
New +$194K 0.03% 216
2024
Q2
Sell
-3,008
Closed -$220K 219
2024
Q1
$220K Sell
3,008
-174
-5% -$13.4K 0.03% 198
2023
Q4
$258K Buy
3,182
+196
+7% +$15.3K 0.05% 187
2023
Q3
$224K Sell
2,986
-239
-7% -$18.4K 0.05% 180
2023
Q2
$249K Sell
3,225
-313
-9% -$25K 0.05% 162
2023
Q1
$294K Sell
3,538
-177
-5% -$14.7K 0.07% 132
2022
Q4
$319K Buy
3,715
+168
+5% +$13.3K 0.08% 134
2022
Q3
$219K Sell
3,547
-773
-18% -$48.7K 0.06% 154
2022
Q2
$264K Sell
4,320
-314
-7% -$19.4K 0.07% 138
2022
Q1
$276K Buy
4,634
+352
+8% +$22.5K 0.06% 149
2021
Q4
$311K Sell
4,282
-223
-5% -$15.4K 0.07% 146
2021
Q3
$312K Sell
4,505
-311
-6% -$21.8K 0.08% 127
2021
Q2
$332K Sell
4,816
-768
-14% -$51.3K 0.09% 119
2021
Q1
$361K Sell
5,584
-2,698
-33% -$174K 0.11% 115
2020
Q4
$483K Buy
+8,282
New +$500K 0.16% 95

Other funds holding GILD

Octavia Wealth Advisors's GILD Position: Q3 2025 in Review

Octavia Wealth Advisors sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 1,847 shares — an estimated $205K sold.

Octavia Wealth Advisors first reported a position in GILD in Q4 2020 and held it in 16 quarters. The position peaked at $483K in Q4 2020. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Octavia Wealth Advisors reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Octavia Wealth Advisors sold 1,847 Gilead Sciences shares in Q3 2025, an estimated $205K.
  • Octavia Wealth Advisors first reported a position in Gilead Sciences in Q4 2020 and held it in 16 quarters.
  • Octavia Wealth Advisors's Gilead Sciences position peaked at $483K in Q4 2020.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Octavia Wealth Advisors's 13F filing for Q3 2025, filed 28 Oct 2025.